Results 171 to 180 of about 108,387 (211)
Some of the next articles are maybe not open access.
[Nonsedative H1 antihistaminics].
Casopis lekaru ceskych, 1991Recent research provided evidence that effective H1-antihistaminic drugs need not exert a central and sedative action. Non-sedative H1-antihistaminics can aptly replace older combined preparations of classical H1-antihistaminics, motivated by an effort to weaken their sedative action by the concurrent administration of pharmaceutical preparations with ...
H, Blehová, J, Metys
openaire +1 more source
Modern H1-antihistamines in asthma
Drug Discovery Today: Therapeutic Strategies, 2006The extensively documented antiallergic and anti-inflammatory properties of second-generation H 1 -antihistamines further enhance their therapeutic potential in asthma. Modern H 1 -antihistamines such as desloratadine, fexofenadine and levocetirizine, with wider therapeutic windows and similar antiallergic and anti-inflammatory properties as the older ...
Prashant S. Borade +3 more
openaire +1 more source
H1-antihistamines in pregnancy and lactation.
Clinical allergy and immunology, 2002Antihistamines may be used for the treatment of allergic rhinitis, upper respiratory infections, urticaria/angioedema, atopic dermatitis, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy. Because these illnesses may affect maternal comfort and safety as well as threaten the fetus directly (anaphylaxis) or indirectly, they often ...
openaire +3 more sources
Cost-effectiveness of H1-antihistamines.
Clinical allergy and immunology, 2002In the health care arena, assessment of a medication's clinical efficacy is no longer enough. It is important to confirm the medication's cost-effectiveness and the improvement in quality of life it provides in relationship to other options in therapy.
openaire +3 more sources
H1-Antihistamine Premedication in NSAID-Associated Urticaria
The Journal of Allergy and Clinical Immunology: In Practice, 2016Therapeutic options for pain management are restricted in patients with nonsteroidal anti-inflammatory drug (NSAID)-induced or NSAID-exacerbated urticaria because strong cyclooxygenase (COX)-I inhibiting NSAID cannot be used. Alternative NSAID such as weak COX-I inhibitors or selective COX-II inhibitors are sometimes not sufficiently effective or have ...
Axel, Trautmann +2 more
openaire +2 more sources
Novel benzothiophene H1-antihistamines for the treatment of insomnia
Bioorganic & Medicinal Chemistry Letters, 2010SAR of lead benzothiophene H(1)-antihistamine 2 was explored to identify backup candidates with suitable pharmacokinetic profiles for an insomnia program. Several potent and selective H(1)-antihistamines with a range of projected half-lives in humans were identified. Compound 16d had a suitable human half-life as demonstrated in a human microdose study,
Wilna J, Moree +19 more
openaire +2 more sources
Comparative safety of H1 antihistamines.
Annals of allergy, 1992In the allergic reaction, mast cells degranulate, releasing inflammatory mediators including histamine. The H1 receptor antihistamines have been developed over the past 50 years to minimize the clinical symptoms caused by this reaction. Currently, H1 antihistamines are taken by approximately 30 million Americans per year.
openaire +1 more source
Paradoxical urticaria to H1‐antihistamines
Journal of the European Academy of Dermatology and VenereologyAngèle Soria +5 more
openaire +2 more sources